Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0538 CHF | -2.18% | +4.26% | +31.22% |
Apr. 17 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
Apr. 17 | Swiss Court OKs Moratorium Extension for Spexis | MT |
- Stock Market
- Equities
- POLN Stock
- News Spexis AG
- Other languages